Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
3,100.00
+150.00 (5.08%)
At close: Sep 4, 2026
| Market Cap | 186.51B -47.4% |
| Revenue (ttm) | 50.34B -39.5% |
| Net Income | -32.83B |
| EPS | -621.40 |
| Shares Out | 60.16M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 269,610 |
| Open | 2,955.00 |
| Previous Close | 2,950.00 |
| Day's Range | 2,915.00 - 3,100.00 |
| 52-Week Range | 2,070.00 - 8,470.00 |
| Beta | -0.44 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 10, 2026 |